NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 286 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,656 | +6787.6% | 1,520,578 | +6552.0% | 0.00% | – |
| Q2 2023 | $13,149 | -99.5% | 22,859 | -94.8% | 0.00% | -100.0% |
| Q1 2022 | $2,392,000 | -61.7% | 443,800 | -4.0% | 0.01% | -64.0% |
| Q4 2021 | $6,246,000 | -34.0% | 462,300 | -12.3% | 0.02% | -40.5% |
| Q3 2021 | $9,467,000 | +3281.1% | 527,100 | +3262.0% | 0.04% | +2000.0% |
| Q1 2020 | $280,000 | -81.5% | 15,678 | -81.1% | 0.00% | -77.8% |
| Q3 2019 | $1,512,000 | -35.6% | 83,000 | +275.6% | 0.01% | -10.0% |
| Q1 2018 | $2,348,000 | +1748.8% | 22,100 | +140.2% | 0.01% | +900.0% |
| Q1 2016 | $127,000 | -56.9% | 9,200 | -47.4% | 0.00% | -50.0% |
| Q4 2015 | $295,000 | -80.4% | 17,500 | -87.3% | 0.00% | -83.3% |
| Q3 2015 | $1,507,000 | – | 137,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |